Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers.
Wu M, Hau PM, Li L, Tsang CM, Yang Y, Taghbalout A, Chung GT, Hui SY, Tang WC, Jillette N, Zhu JJ, Lee HHY, Kong EL, Chan MSA, Chan JYK, Ma BBY, Chen MR, Lee C, To KF, Cheng AW, Lo KW.
Wu M, et al. Among authors: li l.
Nat Commun. 2024 May 3;15(1):3729. doi: 10.1038/s41467-024-48031-8.
Nat Commun. 2024.
PMID: 38702330
Free PMC article.